Home > Insider Trading > Filing (0001181431-13-006517)

Filing Details

Accession Number:: 0001181431-13-006517
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-04 19:09:34
Reporting Period:: 2013-01-31

Filing Date:: 2013-02-04
Accepted Time:: 2013-02-04 19:09:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293310	Kalobios Pharmaceuticals Inc	KBIO	Pharmaceutical Preparations (2834)	770557236

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1108554	Sofinnova Venture Partners V Lp	C/O Sofinnova Ventures 2800 Sand Hill Road, Suite 150 Menlo Park CA 94025	No	No	Yes	No
1130859	Sofinnova Venture Affiliates V Lp	C/O Sofinnova Ventures 2800 Sand Hill Road, Suite 150 Menlo Park CA 94025	No	No	Yes	No
1133066	Sofinnova Venture Principals V Lp	C/O Sofinnova Ventures 2800 Sand Hill Road, Suite 150 Menlo Park CA 94025	No	No	Yes	No
1245624	James Healy	C/O Sofinnova Ventures 2800 Sand Hill Road, Suite 150 Menlo Park CA 94025	Yes	No	Yes	No
1294339	Sofinnova Management V Llc	C/O Sofinnova Ventures 2800 Sand Hill Road, Suite 150 Menlo Park CA 94025	No	No	Yes	No
1362315	Sofinnova Management V 2005, Llc	C/O Sofinnova Ventures 2800 Sand Hill Road, Suite 150 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-01-31	2,923	$8.00	3,173	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2013-01-31	366,592	$8.00	374,205	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2013-01-31	5,485	$8.00	5,601	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

Reflects 1-for-3.56147 reverse stock split which became effective on January 15, 2013.
Shares are held directly by Sofinnova Venture Affiliates V, L.P. ("SV V Affiliates"). Sofinnova Management V, L.L.C. ("SV V LLC"), the general partner of SV V Affiliates, and James I. Healy, a director of the Issuer, Michael F. Powell, and Alain L. Azan, the managing members of SV V LLC, may be deemed to share voting and dispositive power over the shares held by SV V Affiliates. Such persons and entities disclaim beneficial ownership of shares held by SV V Affiliates except to the extent of any pecuniary interest therein.
Shares are held directly by Sofinnova Venture Partners V, L.P. ("SV V Partners"). SV V LLC and Sofinnova Management V 2005, L.L.C. ("SV V 2005 LLC"), the general partners of SV V Partners, and James I. Healy, a director of the Issuer, Michael F. Powell, and Alain L. Azan, the managing members of SV V LLC and SV V 2005 LLC, may be deemed to share voting and dispositive power over the shares held by SV V Partners. Such persons and entities disclaim beneficial ownership of shares held by SV V Partners except to the extent of any pecuniary interest therein.
Shares are held directly by Sofinnova Venture Principals V, L.P. ("SV V Principals"). SV V LLC, the general partner of SV V Principals, and James I. Healy, a director of the Issuer, Michael F. Powell, and Alain L. Azan, the managing members of SV V LLC, may be deemed to have shared voting and dispositive power over the shares owned by SV V Principals. Such persons and entities disclaim beneficial ownership over the shares owned by SV V Principals except to the extent of any pecuniary interest therein.